Cover Image
市場調查報告書

競爭分析:癌症疫苗

Competitor Analysis: Cancer Vaccines

出版商 La Merie Publishing 商品編碼 221876
出版日期 內容資訊 英文 179 Pages
訂單完成後即時交付
價格
Back to Top
競爭分析:癌症疫苗 Competitor Analysis: Cancer Vaccines
出版日期: 2014年03月24日 內容資訊: 英文 179 Pages
簡介

2013年當前,在臨床實驗過程有140種癌症疫苗,不過其中3個產品獲認證、上市,總共達成23億8500萬美元銷售額。臨床實驗中的疫苗中,肽疫苗、蛋白質疫苗佔43%,樹突狀細胞疫苗和癌細胞(株)疫苗為15%,DNA/RNA疫苗佔17%。

本報告提供癌症的預防及治療用疫苗的相關調查、現在進行中的研究開發(R&D)企劃概要(各抗原成分的明細),及各競爭企業趨勢及開發平台資訊(藥物編碼、標的/功能機制、企業概要、產品類型、適應症、進展等)等彙整資料,為您概述為以下內容。

第1章 癌症疫苗:各主要成分的明細

  • 肽疫苗
  • 蛋白質疫苗
  • 個體遺傳型抗體疫苗
  • DNA疫苗(裸/附病毒媒介物)
  • RNA疫苗
  • 類病毒顆粒(VLP)疫苗
  • 樹突狀細胞疫苗
  • 癌細胞或癌細胞株疫苗
  • 微生物學疫苗
  • 其他/未定義的疫苗

第2章 各企業癌症疫苗研究開發平台(共100公司份)

  • ABIVAX
  • Activartis
  • Aduro BioTech
  • Advanced Cancer Therapeutics
  • Advaxis
  • Aeterna Zentaris
  • Agenus
  • Antigen Express
  • ApoVax
  • Ascend Biopharmaceuticals
  • Asterias Biotherapeutics
  • Avax Technologies
  • Bavarian Nordic
  • Bellicum Pharmaceuticals
  • Bharat Biotech
  • Biocon
  • BioLife Science
  • BioNTech
  • Biontech RNA Pharmaceuticals
  • Biovest International
  • Celgene
  • Celldex Therapeutics
  • Cellular Biomedicine
  • CSL
  • CureVac
  • 大日本住友製藥
  • DCPrime
  • Delta-Vir
  • Dendreon
  • Etubics
  • Galena Biopharma
  • Genexine
  • Genticel
  • GlaxoSmithKline
  • Gliknik
  • GlobeImmune
  • Gradalis
  • H. Lee Moffitt Cancer Center and Research Institute
  • Heat Biologics
  • Icon Genetics
  • Immatics biotechnologies
  • Immune Design
  • Immunicum
  • ImmunoCellular Therapeutics
  • ImmunoFrontier
  • Immunovaccine
  • Immunovative Therapies
  • Immutep
  • Innate Immunotherapeutics
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • KAEL-GemVax
  • MabVax
  • Mayo Clinic
  • MediGene
  • Mediolanum
  • Merck
  • Merck Serono
  • Mologen
  • 桃太郎起源
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novartis
  • NovaRx
  • Ohio State University Comprehensive Cancer Center
  • Oncopep
  • OncoTherapy Science
  • Oncothyreon
  • Oncovir
  • 小野藥品工業
  • Oryx
  • 大塚製藥
  • Oxford BioMedica
  • PDS Biotechnology
  • Polynoma
  • Prima Biomed
  • Profectus BioSciences
  • Roche
  • Scancell
  • Shanghai Zerun Biotech Co
  • Shenyang Sunshine Pharmaceutical Co (3SBio)
  • 滋賀醫科大學
  • 鹽野義製藥
  • Sidney Kimmel Comprehensive Cancer Center
  • Stemline Therapeutics
  • TapImmune
  • Targovax
  • Transgene
  • Ultimovacs
  • University Hospital Grenoble
  • University of Arkansas
  • Vaccibody
  • Vaccinex
  • Vaccinogen
  • Vaxart
  • Vaxil Biotherapeutics
  • VAXIMM
  • Vaxon Biotech
  • ViroMed
  • Xiamen Innovax Biotech
  • Zensun Sci & Tech Co

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: LMCA0118

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

Projects are listed according to their main antigenic constituents: peptides, recombinant proteins, idiotype antibody, DNA (plasmid, expression vector), RNA, virus-like particles (VLP), dendritic cells, tumor cells (tumor cell lines), microorganism-based and others.

Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major pharmaceutical markets with combined 2013 sales of US$ 2,385 mln. Peptides and proteins make out 43% of clinical stage cancer vaccines, followed by dendritic cell and tumor cell (line)-based cancer vaccines with each contributing 15% to the clinical cancer vaccine pipeline. DNA- and RNA-based cancer vaccines maked out 17% of the clinical portfolio.

The report includes a compilation of currently active projects in research and development for prophylaxis and therapy of cancer. In addition, the report lists company-specific R&D pipelines of cancer vaccines.

Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

Table of Contents

1. Cancer Vaccines by Main Composition

  • Peptide-based Cancer Vaccines
  • Protein-based Cancer Vaccines
  • Idiotype Antibody-based Cancer Vaccines
  • DNA-based Cancer Vaccines: naked and virally vectored
  • RNA-based Cancer Vaccines
  • Virus-Like Particle (VLP)-based Cancer Vaccines
  • Dendritic Cell-based Cancer Vaccines
  • Tumor Cell and Tumor Cell Line - based Cancer Vaccines
  • Microorganism-based Cancer Vaccines
  • Other and Not Defined Cancer Vaccines

2. Corporate Cancer Vaccines R&D Pipelines

  • ABIVAX
  • Activartis
  • Aduro BioTech
  • Advanced Cancer Therapeutics
  • Advaxis
  • Aeterna Zentaris
  • Agenus
  • Antigen Express
  • ApoVax
  • Ascend Biopharmaceuticals
  • Asterias Biotherapeutics
  • Avax Technologies
  • Bavarian Nordic
  • Bellicum Pharmaceuticals
  • Bharat Biotech
  • Biocon
  • BioLife Science
  • BioNTech
  • Biontech RNA Pharmaceuticals
  • Biovest International
  • Celgene
  • Celldex Therapeutics
  • Cellular Biomedicine
  • CSL
  • CureVac
  • Dainippon Sumitomo Pharma
  • DCPrime
  • Delta-Vir
  • Dendreon
  • Etubics
  • Galena Biopharma
  • Genexine
  • Genticel
  • GlaxoSmithKline
  • Gliknik
  • GlobeImmune
  • Gradalis
  • H. Lee Moffitt Cancer Center and Research Institute
  • Heat Biologics
  • Icon Genetics
  • Immatics biotechnologies
  • Immune Design
  • Immunicum
  • ImmunoCellular Therapeutics
  • ImmunoFrontier
  • Immunovaccine
  • Immunovative Therapies
  • Immutep
  • Innate Immunotherapeutics
  • Inovio Pharmaceuticals
  • ISA Pharmaceuticals
  • KAEL-GemVax
  • MabVax
  • Mayo Clinic
  • MediGene
  • Mediolanum
  • Merck
  • Merck Serono
  • Mologen
  • Momotaro-Gene
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novartis
  • NovaRx
  • Ohio State University Comprehensive Cancer Center
  • Oncopep
  • OncoTherapy Science
  • Oncothyreon
  • Oncovir
  • Ono Pharmaceutical
  • Oryx
  • Otsuka Pharmaceutical
  • Oxford BioMedica
  • PDS Biotechnology
  • Polynoma
  • Prima Biomed
  • Profectus BioSciences
  • Roche
  • Scancell
  • Shanghai Zerun Biotech Co
  • Shenyang Sunshine Pharmaceutical Co (3SBio)
  • Shiga University
  • Shionogi
  • Sidney Kimmel Comprehensive Cancer Center
  • Stemline Therapeutics
  • TapImmune
  • Targovax
  • Transgene
  • Ultimovacs
  • University Hospital Grenoble
  • University of Arkansas
  • Vaccibody
  • Vaccinex
  • Vaccinogen
  • Vaxart
  • Vaxil Biotherapeutics
  • VAXIMM
  • Vaxon Biotech
  • ViroMed
  • Xiamen Innovax Biotech
  • Zensun Sci & Tech Co
Back to Top